Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymyalgia rheumatica

M R Lestico1, L E Boh, A A Schuna

  • 1St. Mary's Hospital Medical Center, Madison, WI.

Clinical Pharmacy
|August 1, 1993
PubMed
Summary

Polymyalgia rheumatica (PMR) typically affects older white females and is treated effectively with corticosteroids. Close monitoring for giant cell arteritis (GCA) is essential due to potential severe complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adherence to alendronate in male veterans.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2007
Same author

New drugs for the treatment of rheumatoid arthritis.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2000
Same author

Lyme disease prevention and vaccine prophylaxis.

The Annals of pharmacotherapy·1999
Same author

Update on treatment of rheumatoid arthritis.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·1998
Same author

Adverse drug events in hospitalized elderly.

The journals of gerontology. Series A, Biological sciences and medical sciences·1998
Same author

Safe use of niacin.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1998

Area of Science:

  • Rheumatology
  • Immunology
  • Epidemiology

Background:

  • Polymyalgia rheumatica (PMR) is a common inflammatory condition primarily affecting individuals over 50.
  • It is characterized by muscle pain and stiffness, particularly in the shoulders and hips.
  • PMR is closely associated with giant cell arteritis (GCA), a serious condition carrying risks of blindness and vascular complications.

Purpose of the Study:

  • To review the epidemiology, pathogenesis, clinical features, diagnosis, and treatment of polymyalgia rheumatica (PMR).
  • To highlight the critical relationship between PMR and giant cell arteritis (GCA).
  • To discuss the management strategies and prognosis for patients with PMR.

Main Methods:

  • Review of existing literature on polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
  • Analysis of epidemiological data, clinical presentations, and laboratory findings.
  • Evaluation of current treatment guidelines and therapeutic outcomes.

Main Results:

  • PMR predominantly affects white females over 50.
  • Elevated erythrocyte sedimentation rate is a key laboratory finding.
  • Corticosteroids, such as prednisone, are highly effective in managing PMR symptoms and laboratory abnormalities within 24-48 hours.

Conclusions:

  • Corticosteroids are the mainstay treatment for polymyalgia rheumatica (PMR), offering rapid symptom relief.
  • Vigilant monitoring for the development of giant cell arteritis (GCA) in PMR patients is crucial.
  • Despite the association with GCA, the prognosis for PMR patients is generally excellent with appropriate management.

Related Experiment Videos